P103 The treatment effect of tonsil-derived mesenchymal stem cells (T-MSCs) via regulating programmed death-1/programmed death ligand-1 (PD-1/PD-L1) in ulcerative colitis
ECCO'20 Vienna
2020
P104 Defective metabolism mediates NK cell dysfunction in inflammatory bowel disease (IBD)
ECCO'20 Vienna
2020
P105 Glutathione S -transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22
ECCO'20 Vienna
2020
P106 Depressive symptoms and anxiety and their screening in IBD patients: performance of the distress thermometer in Italian IBD patients
ECCO'20 Vienna
2020
P107 The expression and regulation of Oncostatin M and its receptor in intestinal inflammation
ECCO'20 Vienna
2020
P108 The importance of developing consensus-driven clinical data standards for Crohn’s disease to amplify data
ECCO'20 Vienna
2020
P109 Construction of a suite of computable biological network models focused on inflammatory bowel disease
ECCO'20 Vienna
2020
P110 Identification of the tryptophan metabolite 3-hydroxyanthranilic acid as a novel tool for the differentiation of Crohn’s disease phenotypes
ECCO'20 Vienna
2020
P112 Body composition and resting energy expenditure in IBD patients receiving biological therapy
ECCO'20 Vienna
2020
P114 A screening tool for the early diagnosis of extraintestinal manifestations in inflammatory bowel disease: the EMAIL questionnaire
ECCO'20 Vienna
2020
P115 Real-world experience of peri-operative treatments on surgical complications after Ileo-caecal resection in Crohn’s disease
ECCO'20 Vienna
2020
P118 A comprehensive evaluation of mucosal redness in patients with ulcerative colitis by linked colour imaging
ECCO'20 Vienna
2020